Urinary Angiostatin-a novel marker of renal pathology chronicity in lupus nephritis

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis

  2012cited by this paper
• Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.

  2011cited by this paper
• Urinary Biomarkers in Lupus Nephritis

  2011cited by this paper
• Distinct roles of CSF-1 isoforms in lupus nephritis.

  2011cited by this paper
• Serum and urinary levels of IL-18 and its inhibitor IL-18BP in systemic lupus erythematosus.

  2010cited by this paper
• Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: preliminary findings

  2010influential reference
• Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis.

  2010cited by this paper
• Urine Proteome Scans Uncover Total Urinary Protease, Prostaglandin D Synthase, Serum Amyloid P, and Superoxide Dismutase as Potential Markers of Lupus Nephritis

  2010cited by this paper
• Ectopic ATP synthase in endothelial cells: a novel cardiovascular therapeutic target.

  2010cited by this paper
• Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis

  2010cited by this paper
• Urinary endothelin-1 in chronic kidney disease and as a marker of disease activity in lupus nephritis.

  2009cited by this paper
• Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study

  2009influential reference
• Initial Validation of a Novel Protein Biomarker Panel for Active Pediatric Lupus Nephritis

  2009cited by this paper
• Urine Osteoprotegerin and Monocyte Chemoattractant Protein-1 in Lupus Nephritis

  2009cited by this paper
• Systemic lupus international collaborating clinics renal activity/response exercise: comparison of agreement in rating renal response.

  2008influential reference
• Altered vascular homeostasis in chronic kidney disease

  2008influential reference
• Biomarkers of lupus nephritis determined by serial urine proteomics.

  2008cited by this paper
• Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index.

  2008cited by this paper
• Are Urinary Levels of Free Light Chains of Immunoglobulins Useful Markers for Differentiating between Systemic Lupus Erythematosus and Infection?

  2008cited by this paper
• Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus.

  2007cited by this paper
• Urine biomarkers predict the cause of glomerular disease.

  2007cited by this paper
• Elevated Urinary VCAM-1, P-Selectin, Soluble TNF Receptor-1, and CXC Chemokine Ligand 16 in Multiple Murine Lupus Strains and Human Lupus Nephritis1

  2007cited by this paper
• Blockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritis.

  2006cited by this paper
• Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus.

  2006cited by this paper
• Urinary proteomic profiles distinguish between active and inactive lupus nephritis.

  2006cited by this paper
• Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus.

  2005cited by this paper
• Structure and function of the plasminogen/plasmin system

  2005cited by this paper
• Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment

  2003cited by this paper
• Urinary soluble VCAM-1 in systemic lupus erythematosus: a clinical marker for monitoring disease activity and damage.

  2002influential reference
• Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.

  2001cited by this paper
• Vascular endothelial growth factor receptors in human mesangium in vitro and in glomerular disease.

  2000cited by this paper
• Hormonal and osmotic regulation of NaCl transport in renal distal nephron epithelium.

  1997cited by this paper
• Angiostatin: a circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth.

  1994cited by this paper
• Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.

  1994cited by this paper
• Urinary levels of IL-6 in patients with active lupus nephritis.

  1993cited by this paper
• The reciprocal effects of epsilon-aminohexanoic acid and chloride ion on the activation of human [Glu1]plasminogen by human urokinase.

  1987cited by this paper
• Prognostic factors in lupus nephritis. Contribution of renal histologic data.

  1983cited by this paper
• Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.

  1981cited by this paper
• Lupus Nephritis

  1959influential reference
• Surface Marker for the Lineage of Monocyte-macrophages in Humans Flt-1, Vascular Endothelial Growth Factor Receptor 1, Is a Novel Cell

  year unknowncited by this paper

• Analytical validation of urine ALCAM ELISA as a test for lupus nephritis

  2023cites this paper
• Effects of anesthetics pentobarbital sodium and chloral hydrate on urine proteome

  2015cites this paper
• Human plasminogen kringle 1-5 inhibits angiogenesis and induces thrombomodulin degradation in a protein kinase A-dependent manner.

  2013cites this paper